Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've picked up a new prescription, or you're managing a long-term condition, and now semaglutide is on the table. Before you start, drug interactions matter: semaglutide can slow the movement of food through your stomach, which affects how quickly other medicines are absorbed into your bloodstream. That slowing effect is the mechanism behind most clinically relevant interactions, and it's why a prescriber needs the full picture of what else you take before approving treatment. Semaglutide is a GLP-1 receptor agonist licensed in the UK for weight management (as Wegovy) and for type 2 diabetes — and in both contexts, interactions with other drugs are assessed individually. These medicines are prescription-only; no pharmacist or prescriber should approve them without reviewing your current medicines list.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the morning routine: a blood-pressure tablet, a thyroid pill, or a statin sitting on the kitchen counter next to the semaglutide pen in the fridge door. You take them together because it's convenient. The problem is that semaglutide reduces how fast the stomach empties its contents into the small intestine, and most oral medicines depend on reaching the intestine within a predictable window to be absorbed properly. When that window shifts, peak drug levels in the blood can drop, or be delayed, or in some cases rise unpredictably depending on the medicine's chemistry.
This gastric-emptying effect is most relevant during the early weeks of treatment and after each dose increase, when the effect is strongest. The NHS semaglutide medicines page lists this as a key mechanism to discuss with your pharmacist or doctor. It is also the reason the prescriber reviewing your consultation at a regulated pharmacy needs an accurate medicines list, not just your headline conditions.
The practical consequence is not that you can never take oral medicines alongside semaglutide. It is that the combination needs to be thought through individually for each drug. Some medicines tolerate a shift in absorption timing without meaningful clinical consequence; others do not. Your prescriber is the person who draws that line.
The interactions most consistently flagged in semaglutide prescribing guidance fall into a few clear categories. Oral contraceptives sit at the top of the list for women of reproductive age. NHS England's guidance on weight-management injections notes that absorption of the combined pill can be affected, and advises discussing contraception options with a clinician before starting. Note that this concern is more pronounced with tirzepatide (Mounjaro) than with semaglutide, but the principle of reviewing your contraception applies to both.
Narrow-therapeutic-index medicines are the next category to flag. These are drugs where the difference between a therapeutic dose and a harmful one is small, and where even a modest shift in absorption timing matters. Warfarin is the textbook example: international normalised ratio (INR) values can drift when gastric emptying changes, so closer INR monitoring is standard practice when semaglutide is introduced. Levothyroxine, used to treat an underactive thyroid, is similarly sensitive to timing; the advice is to take it as instructed (usually first thing, well before food or other medicines) and tell your endocrinologist or GP that you are starting semaglutide.
Diabetes medicines deserve particular attention. If you take insulin or a sulphonylurea (such as gliclazide or glipizide) alongside semaglutide in a diabetes context, the additive glucose-lowering effect raises the risk of hypoglycaemia. Dose adjustments to the existing diabetes medicine are often needed. This is a clinical decision, not a self-management one. For a broader view of what drugs interact with Wegovy, our dedicated page covers specific combinations in more detail.
A question our prescribers hear regularly: does aspirin count? Yes. Any oral medicine that works by being absorbed into the bloodstream is theoretically subject to the gastric-emptying effect. For most people on a low-dose aspirin for cardiovascular protection, the clinical impact is unlikely to be significant, but the semaglutide and aspirin question is worth raising if you take it regularly. NSAIDs like ibuprofen also merit a mention, partly because of the gastric-emptying angle and partly because GLP-1 medicines can occasionally cause nausea and GI discomfort that ibuprofen may worsen.
Supplements are another overlooked category. Iron tablets, calcium supplements and high-dose vitamins are all oral, all absorbed in the gut, and none are automatically exempt. The same timing logic applies: if they are taken alongside semaglutide at a meal, absorption may be affected.
Alcohol is not a medicine but deserves a line: it increases the risk of nausea, and on semaglutide that nausea can be more pronounced than usual. It is not contraindicated outright, but moderation makes the side-effect profile easier to manage. The BNF entry for semaglutide covers formal interaction data if you or a clinician want the professional-level detail. For broader background on the medicine itself, the interactions with Wegovy page explores these themes from a Wegovy-specific angle, and our Wegovy drug interactions guide goes further by setting out how specific drug classes are assessed during a prescribing review.
The most useful thing you can do before starting semaglutide is write down everything you take: prescribed medicines, over-the-counter purchases, vitamins, herbal remedies, and anything else that goes in your mouth daily. That list is what a prescriber works from. At nume, a GPhC-registered independent prescriber reads every consultation personally before approving treatment, which means that list actually gets reviewed, not processed by software and waved through.
After starting, contact your prescriber if you notice an existing condition becoming harder to control, if you experience hypoglycaemia symptoms (shakiness, sweating, confusion) when you haven't had them before, or if a repeat blood test (INR, thyroid function, HbA1c) returns an unexpected result. These are the signals that a drug-level or absorption shift may need clinical attention. You can also reach the support team at any time if a question comes up between consultations.
If you'd like to understand the full picture of your eligibility and current medicines before starting treatment, check your eligibility with a free consultation. A prescriber reviews the whole picture, including what else you take, before any decision is made.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.